Moolec Science (MLEC) Payables (2022 - 2026)
Moolec Science's (MLEC) quarterly Payables came in at $50.6 million in Q1 2026, up 23.4% quarter-over-quarter from $41.0 million in Q4 2025.
Moolec Science (MLEC) Payables (2022 - 2026) Analysis & Trends
Moolec Science has disclosed Payables across 5 years of filings, most recently posting $50.6 million for Q1 2026.
- Payables for Q1 2026 came in at $50.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $50.6 million (changed N/A YoY), and the FY2025 annual result was $234.5 million, down 41.88% from the prior year.
- Payables came in at $50.6 million for Q1 2026 at Moolec Science, up from $41.0 million in the prior quarter.
- In the past five years, Payables ranged from a high of $403.4 million in Q2 2024 to a low of -$4.2 million in Q1 2024.
- The 5-year median for Payables is $1.4 million (2023), against an average of $76.4 million.
- Across the five-year window, Payables surged 20130.71% in 2023 and tumbled 400.01% in 2024, its largest moves.
- Moolec Science's Payables stood at $4.2 million in 2022, then slumped by 166.5% to -$2.8 million in 2023, then soared by 8370.7% to $229.0 million in 2024, then sank by 82.1% to $41.0 million in 2025, then advanced by 23.4% to $50.6 million in 2026.
- The last three Payables figures came in at $50.6 million (Q1 2026), $41.0 million (Q4 2025), and $234.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | 50.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.60 Mn |
| Dec 31, 2025 | 41.01 Mn |
| Jun 30, 2025 | 234.48 Mn |
| Dec 31, 2024 | 229.05 Mn |
| Sep 30, 2024 | -701,192.00 |
| Jun 30, 2024 | 403.45 Mn |
| Mar 31, 2024 | -4.16 Mn |
| Dec 31, 2023 | -2.77 Mn |
| Sep 30, 2023 | 292,432.00 |
| Jun 30, 2023 | 187.48 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 106,219.00 |
| Jun 30, 2022 | 926,711.00 |
| Mar 31, 2022 | 357,860.00 |